Page last updated: 2024-10-25

2-(2-hydroxyethylsulfanyl)-3-methyl-1,4-naphthoquinone and Proliferative Vitreoretinopathy

2-(2-hydroxyethylsulfanyl)-3-methyl-1,4-naphthoquinone has been researched along with Proliferative Vitreoretinopathy in 1 studies

Research Excerpts

ExcerptRelevanceReference
"Three new N(1)-alkylcarbonyl-5-fluorouracil derivatives that are prodrugs of 5-fluorouracil (FU), one of them being a co-drug FU-retinoic acid (RA), were studied as potentially effective drugs against postsurgical proliferative vitreoretinopathy (PVR)."7.72Fluorouracil prodrugs for the treatment of proliferative vitreoretinopathy: formulation in silicone oil and in vitro release of fluorouracil. ( Jolimaître, P; Malet-Martino, M; Martino, R, 2003)
"Three new N(1)-alkylcarbonyl-5-fluorouracil derivatives that are prodrugs of 5-fluorouracil (FU), one of them being a co-drug FU-retinoic acid (RA), were studied as potentially effective drugs against postsurgical proliferative vitreoretinopathy (PVR)."3.72Fluorouracil prodrugs for the treatment of proliferative vitreoretinopathy: formulation in silicone oil and in vitro release of fluorouracil. ( Jolimaître, P; Malet-Martino, M; Martino, R, 2003)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Jolimaître, P1
Malet-Martino, M1
Martino, R1

Other Studies

1 other study available for 2-(2-hydroxyethylsulfanyl)-3-methyl-1,4-naphthoquinone and Proliferative Vitreoretinopathy

ArticleYear
Fluorouracil prodrugs for the treatment of proliferative vitreoretinopathy: formulation in silicone oil and in vitro release of fluorouracil.
    International journal of pharmaceutics, 2003, Jun-18, Volume: 259, Issue:1-2

    Topics: Chemistry, Pharmaceutical; Drug Stability; Fluorouracil; Kinetics; Magnetic Resonance Spectroscopy;

2003